Comparative assessment of the long-term effectiveness and safety of dapagliflozin and empagliflozin as add-on therapy to hypoglycemic drugs in patients with type 2 diabetes

HIGHLIGHTS

• who: Ai-Yu Yang from the Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan have published the article: Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes, in the Journal: Journal of Diabetes Research of 23/05/2022
• what: The authors compared the long-term effectiveness and safety of SGLT2i (dapagliflozin versus empagliflozin) as add-on therapy to hypoglycemic agents in T2D patients.
• how: Patient data were collected using the electronic medical . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.